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Abstract
Background: Complex regional pain syndrome is a painful and disabling post‐trau-
matic primary pain disorder. Acute and chronic complex regional pain syndrome 
(CRPS) are major clinical challenges. In Europe, progress is hampered by significant 
heterogeneity in clinical practice. We sought to establish standards for the diagnosis 
and management of CRPS.
Methods: The European Pain Federation established a pan‐European task force of 
experts in CRPS who followed a four‐stage consensus challenge process to produce 
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1 |  INTRODUCTION
Complex regional pain syndrome (CRPS) is a painful and 
disabling post‐traumatic primary pain disorder affecting, usu-
ally, distal limbs (Birklein, Ajit, Goebel, Perez, & Sommer, 
2018; Marinus et al., 2011). Signs and symptoms are nor-
mally restricted to the affected limb but can spread (van 
Rijn et al., 2011). The incidence of CRPS may vary between 
populations (Sandroni, Benrud‐Larson, McClelland, & Low, 
2003). In a population‐based European study, the incidence 
was 20–26/100,000 in the Netherlands (de Mos et al., 2007).
The clinical presentations of CRPS vary enormously be-
tween patients (Figure 1). For example, the affected limb 
may appear hot and red, or cold and blue; these symptoms 
and signs can also fluctuate in any single patient over time. 
Patients often also report disordered spatial awareness, and 
bodily and limb agency distortions (Lewis, Kersten, McCabe, 
McPherson, & Blake, 2007).
The aetiology of CRPS is likely multifactorial (Birklein et 
al., 2018). It is thought to be pathological not psychopatho-
logical in origin (Beerthuizen et al., 2012; Beerthuizen, van 't 
Spijker, Huygen, Klein, & de Wit, 2009). Most patients will 
improve over time (de Mos et al., 2009; Zyluk, 1998), al-
though appropriate management very likely hastens recovery 
(Gillespie, Cowell, Cheung, & Brown, 2016). However, full 
recovery is less common, and many patients will be left with 
varying degrees of persistent pain and functional impairment 
(Bean, Johnson, Heiss‐Dunlop, & Kydd, 2016). For some 
people, CRPS may become a long‐lasting, highly disabling 
and distressing chronic pain condition. The costs of CRPS are 
significant, at a personal, familial and societal level (Kemler 
& Furnee, 2002; van Velzen et al., 2014).
In 2016, the European Pain Federation convened a CRPS 
Task Force to support the development of best care for these 
patients through Europe. The Task Force members were CRPS 
experts with geographical and professional representation 
within Europe and a patient representative. As its first objective, 
the Task Force was asked to develop standards that could guide 
minimally acceptable levels of CRPS care applicable across a 
diversity of healthcare structures and economies within Europe.
Some European countries have developed their own guide-
lines for CRPS care (Birklein, Humm et al., 2018; Ceruso et 
al.., 2014; Goebel et al., 2018; Perez et al., 2014); however, 
any adoption within additional countries is often impeded by 
differences in healthcare economics and structures. The ap-
plication of standards can go some way to establish a primary 
common position.
We recognize that terms such as “standards,” “guidelines,” 
“policy” and “procedure” are often used interchangeably, and 
currently, there is no internationally agreed definition for the 
term “standards” as applied to health care. For our purposes, 
we considered the UK Faculty of Pain Medicine interpretation 
of standards, as applied to pain: “Standards must be followed. 
Standards aim to represent current best practice in pain man-
agement as published in relevant literature and/or agreed by 
a body of experts” (Grady & al., 2015, p. 8). Notably, stan-
dards can change over time (Figure 2). Standards can act as 
a benchmark, but can also be utilized as a tool for healthcare 
professionals, commissioners and policymakers in the identi-
fication and appropriate allocation of resources.
2 |  METHODS
Our development process followed that outlined by the 
UK National Institute of Clinical Excellence (NICE, see 
Supporting Information Appendix S1). A patient‐member 
(IT) provided service user perspectives. The CRPS standards 
mandatory quality standards worded as grammatically imperative (must‐do) 
statements.
Results: We developed 17 standards in 8 areas of care. There are 2 standards in diag-
nosis, 1 in multidisciplinary care, 1 in assessment, 3 for care pathways, 1 in informa-
tion and education, 4 in pain management, 3 in physical rehabilitation and 2 on 
distress management. The standards are presented and summarized, and their genera-
tion and consequences were discussed. Also presented are domains of practice for 
which no agreement on a standard could be reached. Areas of research needed to 
improve the validity and uptake of these standards are discussed.
Conclusion: The European Pain Federation task force present 17 standards of the 
diagnosis and management of CRPS for use in Europe. These are considered achiev-
able for most countries and aspirational for a minority of countries depending on their 
healthcare resource and structures.
Significance: This position statement summarizes expert opinion on acceptable 
standards for CRPS care in Europe.
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were derived through discussion and a process of consoli-
dation and challenge which had four stages: First, we took 
account of the evidence from recently published systematic 
reviews (Duong, Bravo, Todd, & Finlayson, 2018; O'Connell, 
Wand, McAuley, Marston, & Moseley, 2013). Second, a draft 
document outlining the domains of practice and the likely 
areas of difference was produced and discussed in e‐mail and 
telephone discussions from November 2016 to May 2017. 
Third, we convened a one‐day face‐to‐face meeting in June 
2017. The focus of the meeting was to seek agreement among 
the members of the Task Force on the areas of practice. A 
“challenge” process was developed in which we drafted the 
standards as grammatically imperative (must‐do) statements. 
This presentation of each standard of care as mandatory was 
useful because it forced members to think about exceptional 
cases or alternatives. Finally, a draft document of standards 
was then drafted. Each member of the group had one more 
opportunity to veto any highly contentious area and suggest 
further changes. No veto was enacted.
The resulting standards were considered achievable 
for most countries and aspirational for a minority of coun-
tries depending on their healthcare resource and structures 
(Eccleston, Wells, & Morlion, 2018).
3 |  RESULTS
We developed 17 standards, highlighted in italics, in 8 areas 
of care. There are 2 standards in diagnosis, 1 in multidiscipli-
narity, 1 in assessment, 3 in care pathways, 1 in information 
and education, 4 in pain management, 3 in physical rehabili-
tation and 2 in distress management.
F I G U R E  1  Budapest Diagnostic Criteria for CRPS. Notes: (1) If the patient has a lower number of signs or symptoms, or no signs, but 
signs and/or symptoms cannot be explained by another diagnosis, “CRPS‐NOS” (not otherwise specified) can be diagnosed. This includes 
patients who had documented CRPS signs/symptoms in the past. (2) If A, B, C and D above are all ticked, please diagnose CRPS. If in doubt, or 
for confirmation, please refer to your local specialist. (3) Psychological findings, such as anxiety, depression or psychosis, do not preclude the 
diagnosis of CRPS (3) Distinction between CRPS type 1 (no nerve injury) and CRPS type 2 (major nerve injury) is possible, but has little relevance 
for treatment. Explanation of terms: “Hyperalgesia” is when a normally painful sensation (e.g., from a pinprick) is more painful than normal; 
“allodynia” is when a normally not painful sensation (e.g., from touching the skin) is now painful; and “hyperaesthesia” is when the skin is more 
sensitive to a sensation than normal. A special feature in CRPS: In category 4, the decreased range of motion/weakness is not always due to pain. It 
is also not necessarily due to nerve damage or a joint or skin problem. Some patients’ experience of an inability to move their limb may be due to 
yet poorly understood, disturbed motor coordination which can be reversible. A helpful question to assess this feature is: “If I had a magic wand to 
take your pain away, could you then move your… (e.g., fingers)?” Many patients will answer with “no” to that question. Unusual CRPS: Around 
5% of patients cannot recall a specific trauma or may report that their CRPS developed with an everyday activity such as walking or typewriting. 
In very few people, CRPS can have a bilateral onset. In some patients, CRPS can spread to involve other limbs. Around 15% of CRPS cases do not 
improve after 2 years. It is appropriate to make the diagnosis of CRPS in these unusual cases
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3.1 | The diagnosis of complex regional 
pain syndrome
Complex regional pain syndrome is diagnosed according to 
the “New IASP Criteria” (sensitivity: 0.99; specificity: 0.68 
for the “clinical” criteria) (Harden & Bruehl, 2005; Harden 
et al., 2010) which are sometimes also referred to as the 
“Budapest criteria” (Figure 1).
The use of these criteria requires some degree of prior 
belief that the condition is likely to be CRPS, that is, the pa-
tient has a regional affection distally in extremities, not cor-
responding to a nerve innervation territory. As an exception, 
the rare subtype of CRPS II after nerve injury can sometimes 
correspond to the injured nerve's innervation territory. These 
criteria stipulate that CRPS is a diagnosis of exclusion, and 
alternative (“differential”) diagnoses are provided in Box 1.
Uncertainty about the diagnosis can be distressing to patients 
and may lead to inappropriate treatment. European countries 
differ in their current standards about the timely manner of di-
agnosing CRPS; however, each country is better than the worst 
situation: where patients are never being diagnosed (Figure 2).
Improvements in diagnostic standards are possible and 
desirable through information and training of healthcare pro-
fessionals and patients. For example, in Switzerland an infor-
mation leaflet about CRPS was sent to all practising medical 
doctors in the country, and there is consensus that awareness 
has improved (SUVA, 2013).
While there are “perfect” diagnostic standards, it is im-
portant to establish realistic, country‐related next goals and 
consequently identify which steps that aim to improve cur-
rent standards will help to achieve these goals (see Figure 
2)—this process can later be repeated as appropriate. The 
use of a diagnostic checklist is helpful, as shown in Figure 
1. The European Pain Federation task force members rec-
ognize the challenges about the future development of the 
CRPS Budapest criteria (Table 2); these challenges include, 
among others, the diagnostic approach to a small number of 
patients diagnosed according to Budapest criteria, who over 
time lose some of their CRPS signs such as swelling, but 
have unchanged pain. These patients are currently labelled 
as “CRPS—not otherwise specified” (CRPS‐NOS, Table 2), 
which has sometimes led to challenges with the reimburse-
ment of therapies, or in the context of insurance‐ and med-
ico‐legal proceedings, and a better solution may be required.
Standard 1: “Budapest” diagnostic criteria for 
CRPS must be used, as they provide acceptable 
sensitivity and specificity.
Standard 2: Diagnosing CRPS does not require 
diagnostic tests, except to exclude other diagnoses.
It is worth noting that different opinions existed within 
the Task Force regarding the usefulness of three‐phase bone 
scintigraphy or magnetic resonance imaging for the diagno-
sis of CRPS, with some members considering these tech-
niques useful, and the majority not. There was agreement 
that existing tests do not reflect pathognomonic parameters.
F I G U R E  2  The European Task Force dynamic diagnostic standard quality framework for CRPS. HP: health professional
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3.2 | The management and referral of 
patients with CRPS
Standard 3: The management of mild (mild pain 
and mild disability) CRPS may not require a multi‐
professional team; however, the degree of severity 
and complexity of CRPS must dictate the need for 
appropriately matched multi‐professional care (for 
details, see section care structure and Figure 3).
Standard 4: Patients diagnosed with CRPS 
must be appropriately assessed; this assessment 
must establish any triggering cause of their 
CRPS, their pain intensity and the interference 
their pain causes on their function, their activi-
ties of daily living, participation in other activi-
ties, quality of life, sleep and mood.
Most patients have short‐lasting CRPS which may im-
prove within a few months, even without treatment (Zyluk, 
1998), so that these patients are best treated in non‐special-
ized care, provided by healthcare professionals who have had 
standard training within their discipline (e.g., physiotherapist 
and general practitioner—see Figure 3); early treatment is 
highly likely to shorten the time of suffering for many pa-
tients (Gillespie et al., 2016).
Standard 5: Referral to specialized care must 
be initiated for those patients who do not have 
clearly reducing pain and improving function, 
within 2 months of commencing treatment for 
their CRPS, despite good patient engagement in 
rehabilitation.
There is consensus that the best exact time may vary some-
what between patients, but that 2 months is a reasonable guide.
Standard 6: Referral to super‐specialized care 
must be initiated for the small number of patients 
with complications such as CRPS spread, fixed 
dystonia, myoclonus, skin ulcerations or infec-
tions or malignant oedema in the affected limb, 
and those with extreme psychological distress.
Referral to super‐specialized care may also be appropriate 
for patients which are not improving in specialized services: (a) 
for additional expertise in treating this rare patient group and (b) 
for consideration of interventions not available in specialized 
care (Figure 3).
There was no consensus about the best names for these 
three types of services, although most Task Force members 
considered the current wording in standard 6 to be accept-
able. There is agreement that other wordings may be substi-
tuted as is nationally or locally appropriate.
Treating healthcare professionals should be aware of 
appropriate specialized care services and any services with 
specific expertise and interest in the management of CRPS 
nationally (“super‐specialized” care facilities), Figure 3.
Standard 7: Specialized care facilities must 
provide advanced treatments for CRPS includ-
ing multidisciplinary psychologically informed 
rehabilitative pain management programmes 
(PMP). If they do not provide these treatments, 
then they must refer for these treatments, if 
needed, to other specialized care facilities, or to 
super‐specialized care facilities (Figure 2).
We propose that specialized care facilities (Figure 3), who 
wish to establish quality indicators about their regional CRPS 
pathway, should in the first instance establish an internal reg-
istry of CRPS cases seen. Since the incidence of CRPS in 
Europe (20–26/100,000) is known, such a registry may support 
BOX 1 Possible differential diagnoses
1. Local pathology: Distortion, fracture, pseudoarthro-
sis, arthrosis, inflammation (cellulitis, myositis, vas-
culitis, arthritis, osteomyelitis and fasciitis), 
compartment syndrome and immobilization‐induced 
symptoms. Persistent defects after limb injury: osteo-
arthritis developing after joint fractures; myofascial 
pain due to changed (protective) movement patterns
2. Affection of arteries, veins or lymphatics, for exam-
ple traumatic vasospasm, vasculitis, arterial insuffi-
ciency, thrombosis, Raynaud's syndrome, 
thromboangiitis obliterans (Buerger's syndrome), 
lymphedema and secondary erythromelalgia.
3. Connective tissue disorder
4. Central lesion, for example spinal tumour
5. Peripheral nervous system lesion (nerve compres-
sion, cervico‐brachial or lumbo‐sacral plexus affec-
tion, acute sensory polyneuropathy, (poly‐)neuritis, 
autoimmune (e.g., posttraumatic vasculitis) and in-
fectious (e.g., borreliosis))
6. Malignancy (Pancoast tumour/paraneoplastic syn-
drome/occult malignancy)
7. Factitious disorder
Particular awareness about differential diagnosis is 
advised in spontaneously developing CRPS (no trauma, 
about 5% of cases), when the involvement is a proximal 
part of the limb, such as the shoulder, or when there is 
primary involvement of more than one limb.
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professionals to estimate whether those patients in their region 
who are in need of their service do in fact reach them. The reg-
istry, once established, can also serve as a basis for additional 
quality improvement efforts.
Each Chapter of the European Pain Federation should insti-
tute an appropriate treatment guideline for CRPS that is valid 
for the circumstances in that country, even if this is adapted 
from existing guidelines in other countries. Production of lay 
audience‐appropriate versions should be considered.
3.3 | Prevention
Early, appropriate rehabilitation treatment post‐trauma may 
prevent the development of CRPS; however, more data 
are needed to fully understand its impact (Gillespie et al., 
2016). A high pain score one week after trauma may in-
dicate a “fracture at risk” (Moseley et al., 2014) and thus 
identify patients who benefit most from preventative early 
rehabilitation.
There is conflicting evidence about the value of using vi-
tamin C after distal radius fracture to prevent the develop-
ment of CRPS. There is also very preliminary evidence about 
the value of steroids to prevent a prolonged course of CRPS 
after very early CRPS has been diagnosed. More studies are 
needed before recommendations can be given.
The Task Force decided that there is insufficient evidence 
for or against any methods of prevention to allow for a stan-
dard to be written.
3.4 | Patient information and education
Standard 8: Patients, and where appropriate 
their relatives and carers must receive adequate 
information soon after diagnosis on (a) CRPS, 
(b) its causation (including the limits of current 
scientific knowledge), (c) its natural course, (d) 
signs and symptoms, including body perception 
abnormalities, (e) typical outcomes and (f) treat-
ment options. Provision of information is by all 
therapeutic disciplines and must be repeated as 
appropriate.
Emphasis should be put on the goals of treatment and on the 
patient's active involvement in the treatment plan. The typically 
benign prognosis should be emphasized.
F I G U R E  3  Services and competencies. PMP = multidisciplinary pain management programme integrating psychological care and functional 
rehabilitation; &additionally “Hand Therapists” in some European Countries, *note, some pain clinics and rehabilitation facilities do not provide 
group‐based PMP, whereas others additionally provide “super‐specialized” services; **neuromodulation is listed to highlight the care structure 
within which it is delivered; some centres will not provide this service
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Information is available from various sources (e.g., 
ARUK, 2016; Birklein,  Humm, et al., 2018; Ceruso et al., 
2014; Crpsvereniging, 2018; Goebel et al., 2018; Perez et al., 
2014).
3.5 | Pain management—
medication and procedures
Standard 9: Patients must have access to phar-
macological treatments that are believed to be 
effective in CRPS. Appropriate pain medication 
treatments are considered broadly similar with 
those for neuropathic pains, although high‐qual-
ity studies in CRPS are not available (Duong et 
al., 2018). All patients with CRPS must receive 
a pain treatment plan consistent with any geo-
graphically relevant guidelines.
Treatment with bisphosphonates and/or steroids has also 
been considered. However, the Task Force members did not 
reach agreement about the evidence for or against their effi-
cacy and safety.
Standard 10: Efforts to achieve pain control must 
be accompanied by a tailored rehabilitation plan
Standard 11: Medications aimed at pain relief 
may not be effective in CRPS, while causing 
important adverse effects; therefore, stopping 
rules should be established and a medication 
reduction plan must be in place if on balance 
continuation is not warranted.
Standard 12: CRPS assessment (see above) must 
be repeated as appropriate, because both the nat-
ural development of the disease and of treatment 
may change the clinical picture over time.
Some patients who have not responded to other treatments 
may be considered for invasive neuromodulation and should be 
referred for assessment.
3.6 | Physical and vocational rehabilitation
In partnership with the patient, appropriate, generally gentle, 
graded exercises in the presence of pain should be advised 
upon by a trained healthcare professional; this is essential as 
to give the best chance of a good outcome and minimize dis-
tress. Immobilization of the CRPS limb should be avoided 
wherever possible. (Gillespie et al., 2016; Oerlemans, 
Oostendorp, de Boot, & Goris, 1999/10).
Standard 13: Patient's limb function, overall 
function and activity participation, including 
in the home and at work or school, must be 
assessed early and repeatedly as appropriate. 
Patients should have access to vocational reha-
bilitation (as relevant).
Standard 14: Patients with CRPS must have 
access to rehabilitation treatment, delivered 
by physiotherapists and/or occupational ther-
apists, as early as possible in their treatment 
pathway.
This may shorten the early disease course and preserve limb 
function. In some European countries, these treatments are 
guided by medical doctors, including rehabilitation specialists, 
general practitioners or others.
Standard 15: Physiotherapists and occupa-
tional therapists must have access to training in 
basic methods of pain rehabilitation and CRPS 
rehabilitation
3.7 | Identifying and treating distress
Standard 16: Patients must be screened for 
distress including depression, anxiety, post‐
traumatic stress, pain‐related fear and avoid-
ance. This must be repeated where appropriate 
(Bean, Johnson, Heiss‐Dunlop, Lee, & Kydd, 
2015).
Standard 17: Where required, patients must have 
access to evidence‐based psychological treatment
3.8 | Long‐term care
Some patients will continue to experience impediments to 
their quality of life even after appropriate treatment has been 
completed. These impediments either are due to ongoing con-
sequences of CRPS even though the condition has improved 
(about 40% of all patients), or are caused by unresolved 
CRPS (about 15%‐20%; de Mos et al., 2009). Particularly, 
the latter group may benefit from the offer of a long‐term 
management plan, mainly aiming to maximize support for 
self‐management. Long‐term management is ideally initi-
ated through specialized or super‐specialized services and 
may include referral back to these services if CRPS‐specific 
symptoms change (Figure 3); an example is described here 
(RUHNHSFT, 2016).
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T A B L E  1  European Pain Federation standards for the diagnosis and management of complex regional pain syndrome
Diagnosis Standard 1 “Budapest” diagnostic criteria for CRPS must be used, as they provide acceptable sensitivity and 
specificity.
Standard 2 Diagnosing CRPS does not require diagnostic tests, except to exclude other diagnoses.
Management and 
Referral
Standard 3 The management of mild (mild pain and mild disability) CRPS may not require a multi‐profes-
sional team; however, the degree of severity and complexity of CRPS must dictate the need for 
appropriately matched multi‐professional care (for details, see section care structure and Figure 
3).
Standard 4 Patients diagnosed with CRPS must be appropriately assessed; this assessment must establish 
any triggering cause of their CRPS, their pain intensity and the interference their pain causes on 
their function, their activities of daily living, participation in other activities, quality of life, 
sleep and mood.
Standard 5 Referral to specialized care must be initiated for those patients who do not have clearly reducing 
pain and improving function within 2 months of commencing treatment for their CRPS despite 
good patient engagement in rehabilitation.
Standard 6 Referral to super‐specialized care must be initiated for the small number of patients with 
complications such as CRPS spread, fixed dystonia, myoclonus, skin ulcerations or infections or 
malignant oedema in the affected limb, and those with extreme psychological distress.
Standard 7 Specialized care facilities must provide advanced treatments for CRPS including multidiscipli-
nary psychologically informed rehabilitative pain management programmes (PMP). If they do 
not provide these treatments, then they must refer for these treatments, if needed, to other 
specialized care facilities, or to super‐specialized care facilities (Figure 3).
Prevention None No Standards were considered as having sufficient support to recommend as mandatory.
Information and 
Education
Standard 8 Patients and where appropriate their relatives and carers must receive adequate information soon 
after diagnosis on (a) CRPS, (b) its causation (including the limits of current scientific 
knowledge), (c) its natural course, (d) signs and symptoms, including body perception 
abnormalities, (e) typical outcomes and (f) treatment options. Provision of information is by all 
therapeutic disciplines and must be repeated as appropriate.
Pain Management Standard 9 Patients must have access to pharmacological treatments that are believed to be effective in 
CRPS. Appropriate pain medication treatments are considered broadly similar with those for 
neuropathic pains, although high‐quality studies in CRPS are not available (Duong et al., 2018). 
All patients with CRPS must receive a pain treatment plan consistent with any geographically 
relevant guidelines.
Standard 10 Efforts to achieve pain control must be accompanied by a tailored rehabilitation plan.
Standard 11 Medications aiming at pain relief may not be effective in CRPS, while causing important side 
effects; therefore, stopping rules should be established and a medication reduction plan must be 
in place if on balance continuation is not warranted.
Standard 12 CRPS assessment (see above) must be repeated as appropriate, because both the natural 
development of the disease and of the treatment may change the clinical picture over time.
Physical and 
Vocational 
Rehabilitation
Standard 13 Patient's limb function, overall function and activity participation, including in the home and at 
work or school, must be assessed early and repeatedly as appropriate. Patients should have 
access to vocational rehabilitation (as relevant).
Standard 14 Patients with CRPS must have access to rehabilitation treatment, delivered by physiotherapists 
and/or occupational therapists, as early as possible in their treatment pathway.
Standard 15 Physiotherapists and occupational therapists must have access to training in basic methods of 
pain rehabilitation and CRPS rehabilitation.
Identifying and 
Treating Distress
Standard 16 Patients must be screened for distress including depression, anxiety, post‐traumatic stress, 
pain‐related fear and avoidance. This must be repeated where appropriate.
Standard 16 Where required, patients must have access to evidence‐based psychological treatment.
Long‐term Care None No standards were considered as having sufficient support to recommend as mandatory.
Version January 2019
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4 |  DISCUSSION
We here present 17 standards for the diagnosis and manage-
ment of CRPS for consideration of adoption in Europe. They 
are summarized in Table 1.
These standards can be considered best practice in CRPS 
as supported by expert and patient agreement. We followed a 
method that focused on evidence review but which prioritized the 
production of a series of mandatory statements of optimal clinical 
practice that could be followed in the majority of the 37 countries 
who are members of the European Pain Federation. We delib-
erately avoided statements of optional, desirable or aspirational 
practice, focusing on what was considered achievable by most.
There are a number of limitations to our approach that 
should be taken into account. First, we did not canvas all cli-
nicians working in this field across all of the 37 countries, or 
managers, politicians or other non‐healthcare stakeholders. 
We focused instead on an expert group supported by a patient 
representative. It is possible that different experts would have 
produced different standards. This was a deliberate decision 
on our behalf as we needed to set a first list of expert‐driven 
standards from which to build. Second, we did not produce a 
series of evidence syntheses (e.g., meta‐analytic review of ef-
ficacy or review of assessment tools). We judged that such an 
effort would be resource‐heavy and unlikely to yield any clar-
ity due to the well‐documented absence of primary research 
into this orphan disease. Instead, we relied on the extant lit-
erature which is well known to the group. Third, our decision 
to craft standards as mandatory meant that the heterogeneity 
of different views and nuanced opinions was not reported. 
Presented only is the result.
The standards and their production have clinical, research 
and policy implications.
1. Clinical implications: the next step is to share the stan-
dards with Federation members, which has a number 
of challenges. First, language translation of the standards 
is necessary. Second, we need to survey clinicians for 
current practice as it relates to the standards to establish 
a baseline of common clinical practice.
2. Research implications: there is no standard that could not 
benefit from further study. And there are two areas where 
we were unable to set standards of care. The group consid-
ered that a priority for research was to better understand 
the heterogeneity of presentation within the current broad 
category of CRPS. For example, there is a need to differ-
entiate between an early and late presentation. There is a 
need to look at sex and age differences. And, there is a 
need to look at CRPS in the context of comorbidities. 
There are also challenges to the Budapest criteria which, 
summarized in Table 2, need urgent attention.
3. Policy implications: these standards are the first step in a 
process. Standards are essentially a tool to improve prac-
tice, but practice only improves if they are used. We next 
need to understand the barriers to their implementation, 
whether they are resource, educational, legislative or or-
ganizational. We propose that a CRPS pain champion be 
appointed by each of the 37 national pain chapters, who can 
guide development and be a point of contact for this work.
Finally, we recognize that these standards are open to change 
and should be reviewed regularly. In particular, we need to take 
account of national standards, practice reviews, guidance and 
guidelines, either from individual pain societies or those in re-
habilitation, neurology or other therapy areas. We need also to 
be mindful of non‐European work that could influence these 
standards, including any new and emerging evidence. We have 
therefore agreed with the European Pain Federation to review 
these standards five years from their date of publication.
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